Isotretinoin in Treatment of COVID-19
NCT04361422
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Isotretinoin Only Product in Oral Dose Form
Sponsor
Tanta University